Jonathan French retired from 23 years of teaching Aerospace Physiology and neurosciences at Embry-Riddle Aeronautical University in May 2025. Prior to ERAU, Dr French was an Aerospace Physiologist for the USAF. Before that, he worked for a major pharmaceutical company as part of a team that developed the first FDA approved Alzheimer’s drug. Currently, he continues to research and write papers about the effects of hypoxia on the vestibular system and Aerospace neuropharmacology, among other topics.